Clinical trial
COngenital Multicenter Trial of Pulmonic vAlve Dysfunction Studying the SAPIEN 3 interventIONal THV
NCT02744677 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- COngenital Multicenter Trial of Pulmonic vAlve Dysfunction Studying the SAPIEN 3 interventIONal THV
- Lead sponsor
- Edwards Lifesciences
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 5, 2016
- Completion date
- June 30, 2031
- Enrollment
- 108 (estimated)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.
complex congenital heart defect, dysfunctional rvot conduit, pulmonary valve degeneration, pulmonary valve insufficiency